Liberia gets Ebola drug; ponders who should get

2014-08-15 05:00

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Monrovia - Liberia faced an excruciating choice on Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove either life-saving or life-threatening.

ZMapp, the untested Ebola drug, arrived in the West African country late on Wednesday. Assistant Health Minister Tolbert Nyenswah said three or four people would begin getting it on Thursday. The government had previously said two doctors would receive the treatment, but it was unclear who else would.

These are the last known doses of ZMapp left in the world. The San Diego-based company that developed it has said it will take months to build up even a modest supply.

An Ebola outbreak that began in Guinea and spread to Liberia, Sierra Leone and Nigeria has killed more than 1 060 of the 1 970 people sickened since it was detected in March, according to the World Health Organization. It has overwhelmed the already strained health systems in West Africa and sparked an international debate over the ethics of giving drugs that have not yet been tested for safety or efficacy to the sick.

The charity group Doctors Without Borders, which is running many of the Ebola treatment centres and whose staff have tussled with whether to provide ZMapp, said such choices present "an impossible dilemma."

Now Liberian officials are facing those questions.

"The criteria of selection is difficult, but it is going to be done," said Dr Moses Massaquoi, who helped Liberia obtain the drug from Mapp Biopharmaceutical. "We are going to look at how critical people are. We are definitely going to be focusing on medical staff."

Massaquoi said people who were past the "critical phase" and looked likely to survive would not be treated with it.

In this outbreak, over 50% of those getting Ebola have died, according to the UN health agency.

So far, ZMapp has been given to three people: two Americans and a Spaniard priest. The Americans are improving - but it is unclear what role the drug has played. The Spaniard died earlier this week in Madrid.

Nigeria announced on Thursday that one more person has been infected with Ebola, bringing the country's number of cases to 11. Health Minister Onyebuchi Chukwu said the latest patient is a doctor who helped treat the first Ebola case in the country, Liberian-American Patrick Sawyer who flew in last month with the virus and died 25 July.

All Nigerians who contracted the virus have had direct contact with Sawyer.

Read more on:    liberia  |  ebola  |  west africa  |  zmapp

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
1 comment
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.